Recombinant Liver Stage Antigen-1 (LSA-1) formulated with AS01 or AS02 is safe, elicits high titer antibody and induces IFN-γ/IL-2 CD4+ T cells but does not protect against experimental Plasmodium falciparum infection

This publication has 32 references indexed in Scilit:

• Phenotype and function of human T lymphocyte subsets: Consensus and issues
  Cytometry Part A, 2008
• Impact of Recombinant Adenovirus Serotype 35 Priming versus Boosting of aPlasmodium falciparumProtein: Characterization of T- and B-Cell Responses to Liver-Stage Antigen 1
  Infection and Immunity, 2008
• Preclinical Evaluation of the Safety and Immunogenicity of a Vaccine Consisting ofPlasmodium falciparumLiver-Stage Antigen 1 with Adjuvant AS01B Administered Alone or Concurrently with the RTS,S/AS01B Vaccine in Rhesus Primates
  Infection and Immunity, 2008
• Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major
  Nature Medicine, 2007
• Priming with an Adenovirus 35-Circumsporozoite Protein (CS) Vaccine followed by RTS,S/AS01B Boosting Significantly Improves Immunogenicity toPlasmodium falciparumCS Compared to That with Either Malaria Vaccine Alone
  Infection and Immunity, 2007
• Interleukin-10 production by effector T cells: Th1 cells show self control
  The Journal of Experimental Medicine, 2007
• Murine Immune Responses to Liver-Stage Antigen 1 Protein FMP011, a Malaria Vaccine Candidate, Delivered with Adjuvant AS01B or AS02A
  Infection and Immunity, 2007
• Process Development and Analysis of Liver-Stage Antigen 1, a Preerythrocyte-Stage Protein-Based Vaccine forPlasmodium falciparum
  Infection and Immunity, 2005
• Gamma Interferon Responses toPlasmodium falciparumLiver-Stage Antigen 1 and Thrombospondin-Related Adhesive Protein and Their Relationship to Age, Transmission Intensity, and Protection against Malaria
  Infection and Immunity, 2004
• Non-CS pre-erythrocytic protective antigens
  Immunology Letters, 1990